bovine pulmonary artery endothelial cells (bpaecs) Search Results


n bovine pulmonary artery endothelial cells bpaecs  (Cell Applications Inc)
93
Cell Applications Inc n bovine pulmonary artery endothelial cells bpaecs
N Bovine Pulmonary Artery Endothelial Cells Bpaecs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n bovine pulmonary artery endothelial cells bpaecs/product/Cell Applications Inc
Average 93 stars, based on 1 article reviews
n bovine pulmonary artery endothelial cells bpaecs - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
bovine pulmonary artery endothelial cells (bpaecs)  (Genlantis inc)
90
Genlantis inc bovine pulmonary artery endothelial cells (bpaecs)
GHRHAnt counteract toxin-induced ROS generation. <t>BPAECs</t> exposed to vehicle (0.1% DMSO) or GHRHAnt (1 μM) for 8 h were post-treated with vehicle (PBS), ( A ) LPS (10 μg/mL), or ( B ) LTA (10 μg/mL) for 4 h. Results represent 4 independent experiments. ( A ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LPS. ( B ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LTA. n = 4. Means ± SEM.
Bovine Pulmonary Artery Endothelial Cells (Bpaecs), supplied by Genlantis inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bovine pulmonary artery endothelial cells (bpaecs)/product/Genlantis inc
Average 90 stars, based on 1 article reviews
bovine pulmonary artery endothelial cells (bpaecs) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bovine pulmonary artery endothelial cells bpaec passage 5–10  (Cambrex)
90
Cambrex bovine pulmonary artery endothelial cells bpaec passage 5–10
GHRHAnt counteract toxin-induced ROS generation. <t>BPAECs</t> exposed to vehicle (0.1% DMSO) or GHRHAnt (1 μM) for 8 h were post-treated with vehicle (PBS), ( A ) LPS (10 μg/mL), or ( B ) LTA (10 μg/mL) for 4 h. Results represent 4 independent experiments. ( A ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LPS. ( B ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LTA. n = 4. Means ± SEM.
Bovine Pulmonary Artery Endothelial Cells Bpaec Passage 5–10, supplied by Cambrex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bovine pulmonary artery endothelial cells bpaec passage 5–10/product/Cambrex
Average 90 stars, based on 1 article reviews
bovine pulmonary artery endothelial cells bpaec passage 5–10 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


GHRHAnt counteract toxin-induced ROS generation. BPAECs exposed to vehicle (0.1% DMSO) or GHRHAnt (1 μM) for 8 h were post-treated with vehicle (PBS), ( A ) LPS (10 μg/mL), or ( B ) LTA (10 μg/mL) for 4 h. Results represent 4 independent experiments. ( A ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LPS. ( B ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LTA. n = 4. Means ± SEM.

Journal: Endocrines

Article Title: Protective Activities of Growth Hormone-Releasing Hormone Antagonists against Toxin-Induced Endothelial Injury

doi: 10.3390/endocrines5010008

Figure Lengend Snippet: GHRHAnt counteract toxin-induced ROS generation. BPAECs exposed to vehicle (0.1% DMSO) or GHRHAnt (1 μM) for 8 h were post-treated with vehicle (PBS), ( A ) LPS (10 μg/mL), or ( B ) LTA (10 μg/mL) for 4 h. Results represent 4 independent experiments. ( A ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LPS. ( B ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LTA. n = 4. Means ± SEM.

Article Snippet: Bovine pulmonary artery endothelial cells (BPAECs) are available from Genlantis (San Diego, CA, USA).

Techniques:

GHRHAnt suppress endothelial barrier dysfunction-induced NEK2 augmentation. ( A ) Western blot (WB) analysis of NEK2 and β-actin protein expression in BPAECs exposed to VEH (0.1% DMSO) or GHRHAnt (1 μM) (8 h) and post-treated with VEH (PBS) or LPS (10 μg/mL) (4 h). WB analysis of NEK2 and β-actin in ( B ) BPAECs and ( C ) HUVECs exposed to VEH (PBS) or IFN-γ (4 μg/mL) (24 h) and post-treated with VEH (0.1% DMSO) or GHRHAnt (1 μM) (8 h). Signal intensity was analyzed by densitometry. Protein levels of NEK2 were normalized to β-actin (loading control). Results represent 3 independent experiments. ( A ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LPS. ( B,C ) * p < 0.05 vs. VEH, $ p < 0.05 vs. IFN-γ. n = 3. Means ± SEM.

Journal: Endocrines

Article Title: Protective Activities of Growth Hormone-Releasing Hormone Antagonists against Toxin-Induced Endothelial Injury

doi: 10.3390/endocrines5010008

Figure Lengend Snippet: GHRHAnt suppress endothelial barrier dysfunction-induced NEK2 augmentation. ( A ) Western blot (WB) analysis of NEK2 and β-actin protein expression in BPAECs exposed to VEH (0.1% DMSO) or GHRHAnt (1 μM) (8 h) and post-treated with VEH (PBS) or LPS (10 μg/mL) (4 h). WB analysis of NEK2 and β-actin in ( B ) BPAECs and ( C ) HUVECs exposed to VEH (PBS) or IFN-γ (4 μg/mL) (24 h) and post-treated with VEH (0.1% DMSO) or GHRHAnt (1 μM) (8 h). Signal intensity was analyzed by densitometry. Protein levels of NEK2 were normalized to β-actin (loading control). Results represent 3 independent experiments. ( A ) * p < 0.05 vs. VEH, $ p < 0.05 vs. LPS. ( B,C ) * p < 0.05 vs. VEH, $ p < 0.05 vs. IFN-γ. n = 3. Means ± SEM.

Article Snippet: Bovine pulmonary artery endothelial cells (BPAECs) are available from Genlantis (San Diego, CA, USA).

Techniques: Western Blot, Expressing, Control